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The Early Time Course of Smoking Withdrawal Symptoms
Peter S. Hendricks
ABSTRACT
Despite the large volume of research on tobacco withdrawal, the vast majority of studies have
focused on the onset and remission of symptoms over the course of several days and weeks, with
the earliest assessment periods occurring the day after cessation. To date, there has been no
systematic study of the very early time course of the tobacco withdrawal syndrome, despite its
obvious relevance to the maintenance of both smoking and postcessation abstinence. The
published literature contains a range of estimates about the early appearance of withdrawal
symptoms, but without reference to empirical data. The main objective of the current study was
to conduct a comprehensive, multimodal assessment of the early time course of the symptoms
associated with smoking withdrawal among cigarette smokers. Participants were 50 smokers
randomly assigned to either abstain or smoke at their own pace during four hours in the
laboratory. Dependent measures included a physiological measure (resting heart rate); sustained
attention (the Rapid Visual Information Processing task; RVIP); selective attention to smoking
stimuli (an emotional Stroop task); and self-report (the Wisconsin Smoking Withdrawal Scales;
WSWS). After baseline assessment, participants were assigned to the two conditions and the
dependent measures were collected every 30 minutes. Generalized Estimating Equations (GEEs)
revealed that abstinent participants displayed greater withdrawal than continuing smokers on all
measures with the exception of the Stroop task. Statistically significant differences in withdrawal
were found within 60 minutes on heart rate, within 30 minutes on the RVIP, and between 30
minutes and 180 minutes postcessation on the various subscales of the WSWS. These findings
provide the first evidence of the early time course of tobacco withdrawal symptoms, although
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further research is needed to distinguish withdrawal effects from drug offset effects. Implications
for the understanding the maintenance of daily smoking and for the treatment of tobacco
dependence are discussed.
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Introduction
Cigarette smoking remains the single most preventable cause of morbidity and mortality
in the United States (US Department of Health and Human Services, 2000), accounting for
approximately one in five deaths or 440,000 deaths per year (Centers for Disease Control, 2002a).
Smoking is responsible for more than 30% of all cancer mortalities (American Cancer Society,
2003), including 87% of lung cancer deaths (US Department of Health and Human Services,
1989). Although the prevalence of smoking has declined over the past 25 years, 46.5 million
individuals remain addicted to cigarettes (Centers for Disease Control, 2002b), with an additional
3000 adolescents becoming addicted each day (Centers for Disease Control, 1995). Furthermore,
evidence suggests that today’s smokers may be more difficult to treat than those of the past (Irvin
& Brandon, 2000; Irvin, Hendricks, & Brandon, 2003). Thus, it is essential that researchers
continue to investigate the factors involved in the maintenance of cigarette smoking.
Withdrawal, defined as temporary maladaptive behavior change following the cessation
or reduction of substance use that causes distress or impairment, is acknowledged as a
pathognomonic sign of addiction in several models of drug-use behavior (e.g., American
Psychiatric Association, 2000, 1994, 1987; Crabbe, 2002; Edwards, Arif, & Hodgson, 1981). For
several decades withdrawal symptoms have been considered powerful factors in the maintenance
of dependence and relapse to drug use (e.g., Eddy, Halbach, Isbell, & Seevers, 1965; Wikler,
1973). Indeed, numerous researchers have proposed that an individual’s desire to use a drug (i.e.,
urge or craving) is strongly associated with drug withdrawal (Tiffany, 1990). For instance,
Marlatt (1978) suggested that craving is the anticipation of, and desire for, the relief of
withdrawal.
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Classic addiction theory emphasizes that withdrawal is caused by the homeostatic
adaptation of the nervous system to chronic drug use. When drug use is discontinued, the central
nervous system must readapt to the absence of the drug in the body, giving rise to aversive
withdrawal symptoms. Renewal of drug self-administration restores homeostasis, thereby
alleviating withdrawal. Thus, under classic theory, the primary motivation for substance use is
negative reinforcement (e.g., Baker, Piper, McCarthy, Majeskie, & Fiore, 2004; Benowitz, 1991,
Siegel, 1983; Solomon, 1977).
With regard to tobacco, ample evidence suggests that nicotine is the responsible agent for
the addictive nature of cigarette use (Baker, Brandon, & Chassin, 2004; US Department of Health
and Human Services, 1988). For example, nicotine increases synaptic dopamine activity, which
is thought to enhance mood (Picciotto, 1998). A number of studies suggest that nicotine plays a
substantial role in the reduction of anxiety (Gilbert, Robinson, Chamberlin, & Spielberger, 1989;
Hatch, Bierner, & Fisher, 1983; Juliano & Brandon, 2002; Kassel & Unrod, 2000; Pomerleau,
Turk, & Fertig, 1984). Moreover, nicotine administration reduces subsequent cigarette use
among smokers (Perkins et al., 1996) and smokers will not use de-nicotinized cigarettes on a
chronic basis (Caggiula et al., 2001). Importantly, nicotine readily reverses smoking-related
withdrawal symptoms (Hughes, Higgins, & Hatsukami, 1990). For this reason, the terms
“nicotine withdrawal,” “tobacco withdrawal,” and “smoking withdrawal” are used
interchangeably.
Despite the importance of nicotine to smoking addiction, research suggests that the
sensorimotor aspects of smoking (e.g., the taste, smell, and respiratory tract sensations involved
in using cigarettes) produce effects beyond those of nicotine alone and contribute to
reinforcement from cigarette use (Perkins, Grobe, Stiller, Fonte, & Goettler, 1992; Rose, Behm,
Westman, & Johnson, 2000; Westman, Behm, & Rose, 1996). Indeed, several studies have
demonstrated the importance of these sensations in relieving craving for cigarettes and promoting
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abstinence (Behm, Schur, Levin, Tashkin, & Rose, 1993; Westman et al., 1996). Thus, with
regard to cigarette use, withdrawal may be best conceptualized as withdrawal from the complete
act of smoking rather than from nicotine per se (see Hendricks, Phillips, & Brandon, 2003).
Various investigators have examined the effects of smoking abstinence on myriad
psychological, behavioral, and physiological processes (see Hughes et al., 1990). Hughes and
colleagues (e.g., Hughes, 1992a, 1992b; Hughes, Gust, Skoog, Keenan, & Fenwick, 1991;
Hughes & Hatsukami, 1986; Hughes, Hatsukami, Pickens, & Svikis, 1984) have identified a
group of withdrawal symptoms that are both reliable and valid. This withdrawal syndrome
consists of urge/craving to smoke, irritability, anxiety, depression/dysphoria, difficulty
concentrating, restlessness, sleep disturbance, decreased heart rate, and increased appetite. These
symptoms, which can be largely conceptualized as a cluster of negative affective responses
(Baker, Piper, et al., 2004; Piasecki, Fiore, & Baker, 1998; Kenford et al., 2002; Piasecki,
Jorenby, Smith, Fiore, & Baker, 2003a, 2003b, 2003c; Piasecki, Kenford, Smith, Fiore, & Baker,
1997; Piasecki et al., 2000), tend to increase markedly during the first week of abstinence and
then decrease to preabstinence levels within one to four weeks in most people (Hughes et al.,
1990).
Although the transient effects of cessation on the symptoms listed above suggest that they
are due to withdrawal, an alternative explanation exists. The changes that occur following
abstinence may represent offset effects, which are conceptualized as sustained changes following
the cessation or reduction of smoking (Hughes et al., 1990). Offset effects are thought to
represent the termination of the effects of cigarette use and the return to predrug baseline values.
Although it is difficult to differentiate withdrawal from offset effects (Benowitz, 1998; Hughes,
1991; Shiffman, West, & Gilbert, 2004), there appears to be adequate evidence that the symptoms
that comprise the withdrawal syndrome are indeed withdrawal effects (e.g., Hughes, 2005c;
Hughes et al., 1990). Still, whereas it may be more accurate to refer to the changes following
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cessation as abstinence effects (i.e., any effects, including withdrawal and offset, that result from
the discontinuation of cigarette use), a survey of the literature would reveal, with rare exception,
the use of the term withdrawal.
Measurement of Withdrawal
Heart rate. Several studies have shown that abstinence from smoking results in
decreased heart rate. Indeed, as mentioned previously, decreased heart rate is considered a
reliable and valid index of smoking withdrawal (e.g., American Psychiatric Association, 1994;
Hughes et al., 1990). However, it appears that this matter is being reconsidered in the research
literature. Hughes (2005a) asserted that it is unclear whether drop in heart rate is a withdrawal or
offset effect, and Shiffman et al. (2004) concluded that decreased heart rate is very likely a result
of offset. Nevertheless, investigations have consistently demonstrated decreased heart rate with
abstinence using both automated instruments (e.g., Drobes & Tiffany, 1997; Giannakoulas,
Katramados, Melas, Diamantopoulos, & Chimonas, 2003; Killen et al., 2001) and manual pulse
measurements (e.g., Hughes, 1992b).
Self-report. The majority of studies have measured withdrawal via subjective self-report
measures such as the Withdrawal Symptoms Checklist (WSC; Shiffman & Jarvik, 1976), the
Smoker Complaint Scale (SCS; Schneider, Jarvik, & Forsythe, 1984), and the Minnesota Nicotine
Withdrawal Scale (MNWS; Hughes & Hatsukami, 1986). The MNWS is the most frequently
used measure of withdrawal, and comprises items that generally reflect those symptoms listed by
the DSM-IV as part of the nicotine withdrawal syndrome (American Psychiatric Association,
1994). These items include craving, irritability, anxiety, depressed mood, difficulty
concentrating, restlessness, sleep disturbance, and increased appetite.
Despite its widespread application, the MNWS has been the target of recent criticism
(e.g., Patten & Martin, 1996; Welsch et al., 1999). Welsch et al. (1999) argued that, because it
uses single items to index symptom domains, the MNWS is limited in its ability to identify
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individual withdrawal symptoms. They further asserted that the single-item nature of the MNWS
inflates item-specific error and prevents the assessment of internal consistency. Citing the
questionable psychometric properties of other measures of withdrawal (i.e., the WSC and SCS)
the authors offered their own Wisconsin Smoking Withdrawal Scale (WSWS) as the best measure
of smoking withdrawal. The 28-item WSWS contains seven subscales: Anger, Anxiety,
Concentration, Craving, Hunger, Sadness, and Sleep, each with strong reliability indices. These
subscales relate directly to six of the eight DSM-IV symptoms of nicotine dependence.
Furthermore, the WSWS significantly predicted nicotine replacement treatment and abstinence
more successfully than the MNWS. Initial evidence therefore supports the WSWS as the best
self-report measure of smoking withdrawal.
Attention tasks. An extensive volume of research has investigated the effects of
smoking/nicotine on human cognitive processing and performance (for a review, see Heishman,
Taylor, & Henningfield, 1994). Although the processes by which smoking may affect cognitive
performance are not entirely understood, the accumulation of evidence suggests that nicotine
affects attentional processing (Kassel, 1997). The majority of studies that have examined the
impact of smoking/nicotine on attention have compared the performance of deprived smokers
(i.e., those who maintain abstinence the night prior to testing) to nondeprived smokers (i.e., those
who smoke shortly before or during testing) (for a recent example, see al’Absi, Amunrud, &
Wittmers, 2002). It is therefore difficult to determine whether smoking enhances attentional
processing or reverses a withdrawal-induced deficit (Hughes, 1991). Although this issue has
been the focus of some debate (see Heishman, Henningfield, & Singleton, 2002, and Pritchard &
Robinson, 2000), comprehensive, critical reviews of the literature (e.g., Heishman, 1998;
Heishman et al., 1994; Sherwood, 1993) have concluded that abstinence from smoking impairs
attentional performance and smoking or nicotine produce small positive effects in performance
only under limited conditions.
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A wide array of attention tasks has been used to measure the effects of smoking
abstinence. Examples include the circle/dot stimulus task (Hughes, Keenan, & Yellin, 1989),
letter cancellation (Parrott & Roberts, 1991), cued target detection (Shirtcliff & Marrocco, 2003),
paced auditory serial addition (al’ Absi et al., 2002), and visual attentional vigilance (e.g.,
Hirshman, Rhodes, Zinser, & Merritt, 2004). In addition, multitest batteries have been used that
include trail making, serial digit learning, symbol digit modalities, and the circle/dot stimulus task
(Hatsukami, Fletcher, Morgan, Keenan, & Amble, 1989), and letter search, logical reasoning,
digit recall, and mental arithmetic (Bell, Taylor, Singleton, Henningfield, & Heishman, 1999;
Snyder, Davis, & Henningfield, 1989; Snyder & Henningfield, 1989; Shiffman, Paty, Gnys,
Kassel, & Elash 1995; Shiffman et al., 2000).
Although many investigations have demonstrated that abstinence from smoking results in
deficits in performance, others have failed to show such an effect (Heishman et al., 1994). For
this reason, it has been suggested that withdrawal-related impairment is specific to certain
cognitive tests (Bell et al., 1999). Indeed, whereas smoking abstinence has been consistently
associated with impairment in tasks of sustained attention, less consistent results have been found
with tasks of selective and divided attention (Heishman et al., 1994; Kassel, 1997; Mancuso,
Lejeune, & Ansseau, 2001; Mancuso, Warburton, Mélen, Sherwood, & Tirelli, 1999; Warburton,
1998). By definition, sustained attention tasks require energetic attentional resources or effort. In
contrast, selective attention tasks require the ability to exclude competing sources of information
and divided attention tasks require the ability to share attention among two or more sources of
information (Heishman et al., 1994; Mancuso et al., 2001; Mancuso, Warburton, et al., 1999;
Kassel, 1997).
The most frequently used task of sustained attention among smokers is the Rapid Visual
Information Processing task (RVIP; Wesnes & Warburton, 1983). In the RVIP, a series of single
digits are presented on a computer screen at a rapid pace. Participants are instructed to press a
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response button whenever they notice three consecutive odd or even digits. Abstinence from
smoking has been consistently shown to impair RVIP performance in smokers (e.g., Baldinger,
Hasenfratz, & Bättig, 1995; Edwards, Wesnes, Warburton, & Gale, 1985; Foulds et al., 1996;
Hasenfratz & Bättig, 1993; Lawrence, Ross, & Stein, 2002; Mancuso, Andres, Ansseau, &
Tirelli, 1999; Parrott & Craig, 1992; Parrott & Winder, 1989; Petrie & Deary, 1989; Revell, 1988;
Warburton & Arnall, 1994; Warburton & Mancuso, 1998; Wesnes & Warburton, 1983, 1984;
Zack, Belsito, Scher, Eissenberg, & Corrigall, 2001) with rare exception (e.g., Cook, Gerkovich,
Graham, Hoffman, & Peterson, 2003). Thus, the RVIP appears to be among the best measures of
withdrawal-related attentional capacity.
Emotional Stroop task. For over 70 years, investigations using the Stroop task (Stroop,
1935) have examined human attentional bias. In the classic version of the Stroop task,
participants are presented with stimuli printed in different colors and asked to name the color of
each stimulus as quickly and accurately as possible while ignoring its meaning. Stimuli include
actual color words or meaningless stimuli such as nonsense letter strings. Hundreds of studies
involving the classic Stroop design have found that it takes participants longer to indicate the
color of incongruent color words (e.g., the word “blue” printed in red ink) compared to
meaningless stimuli (for a review, see MacLeod, 1991). This phenomenon is known as the
Stroop effect. Although the mechanisms underlying the Stroop effect are not completely
understood, the leading theory (Cohen, Dunbar, & McClelland, 1990) states that the interference
of performance is a result of two distinct, automatic cognitive processes (color naming and word
reading) competing for a single source of behavioral output.
Researchers have used adaptations of the original Stroop task to investigate attentional
bias in various forms of emotional disturbance (i.e., psychopathology; for a review, see Williams
et al., 1996). In these “emotional” Stroop tasks, participants are presented with neutral/positive
words and words that are related to their pathology. For example, Gotlib and McCann (1984)
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presented neutral, positive, and depression-related words to participants who displayed mild or no
depressive symptoms. Participants with mild depressive symptoms took significantly longer to
name the color of depression-related words compared to both the neutral and positive words. The
emotional Stroop task has been used with a range of pathology including generalized anxiety
disorder, panic disorder, posttraumatic stress disorder, obsessive-compulsive disorder, social
phobia, specific phobias, depressive disorders (Williams et al., 1996), eating disorders (e.g.,
Channon, Hemsley, & de Silva, 1988; Cooper, Anatasiades, & Fairburn, 1992), alcohol use (e.g.,
Carrigan, Drobes, & Randall, 2004; Johnsen, Laberg, Cox, Vaksdal, & Hugdahl, 1994; Jones &
Schulze, 2000; Kramer & Goldman, 2003; Sharma, Albery, & Cook, 2000; Stetter, Ackermann,
Bizer, Straube, & Mann, 1995), and heroin use (e.g., Franken, Croon, Wiers, & Jansen, 2000). In
most cases, participants display greater color-naming latency to words related to their pathology
than neutral/positive words, suggesting that the pathology-related words capture participants’
attention, thereby interfering with color-naming (Williams et al., 1996). Although it is unclear
why participants display attentional bias to pathology-related words (Williams et al., 1996),
recent evidence suggests that it may be the emotional salience of the cues that disrupts processing
(Compton et al., 2003).
Additional research has focused on attentional bias and its relationship to smoking
abstinence. Gross, Jarvik, and Rosenblatt (1993) administered an emotional Stroop task to male
smokers who had either been abstinent for 12 hours or who had smoked normally for the same
period of time. Participants were presented with words that were neutral in meaning or smokingrelated (e.g., cigarette, smoke). Abstinent smokers took significantly longer to color-name
smoking-related words versus neutral words, whereas nonabstinent smokers did not display such
a Stroop effect. Johnsen, Thayer, Laberg, and Asbjornsen (1997) administered a similar
emotional Stroop task to active smokers, abstinent smokers in treatment, and nonsmokers. The
authors found that only active smokers displayed a Stroop effect and suggested that, consistent
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with previous research (e.g., Watts, McKenna, Sharrock, & Trezise, 1986), treatment of the
abstinent smokers had resulted in decreased attentional bias to smoking stimuli. Wertz and
Sayette (2001) administered an emotional Stroop task to smokers who had been abstinent for 12
hours and were told they would, would not, or might be able to smoke during the experiment. All
participants displayed a significant Stroop effect. Furthermore, those participants who were told
they would be able to smoke during the study displayed the largest Stroop effect, a finding that
paralleled data from a previous study of smoking availability and self-reported urge (Juliano &
Brandon, 1998). Zack et al. (2001) administered the emotional Stroop task to adolescent smokers
who had abstained from smoking overnight, encouraged the participants to smoke a cigarette at
their own pace, and then readministered the task. Participants took significantly longer to colorname smoking words while abstinent than immediately after smoking. In addition, reaction time
to smoking words was positively correlated with factor two (desire to smoke to relieve
withdrawal) of the Questionnaire of Smoking Urges (QSU, Tiffany & Drobes, 1991). Waters and
Feyerabend (2000) administered an emotional Stroop task to smokers who had either been
abstinent for 24 hours or smoked normally. Abstinent smokers displayed a significantly greater
Stroop effect than nonabstinent smokers, and the size of the effect predicted participants’ selfreported time to smoking their first cigarette of the day. Using a similar design, Waters,
Shiffman, et al. (2003) administered an emotional Stroop task to smokers in cessation who were
either using the placebo or active nicotine patch. They found that participants using the placebo
patch made more errors on smoking-related words relative to those using the active patch.
Reaction time to smoking-related words predicted outcome (i.e., early lapse) for all participants.
Although none of these studies examined the relationship between performance on the
Stroop task and withdrawal symptoms other than urge/craving, several of the authors (Gross et
al., 1993; Waters, Shiffman, et al., 2003; Wertz & Sayette, 2001; Zack et al., 2001) suggested that
performance is influenced by motivational state (i.e., withdrawal-related urge/craving) at the time
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of administration. Furthermore, they suggested that the emotional Stroop task may capture
motivational information not accounted for by traditional self-report measures, thus providing an
alternative index of urge/craving. Indeed, it has been suggested that measures such as the
emotional Stroop are desirable because they may tap information that is not available to
conscious awareness (Hendricks & Brandon, 2005; Reich, Goldman, & Noll, 2005). In addition,
it is believed that measures such as the Stroop do not create the demand characteristics common
in self-report measures (Greenwald & Banaji, 1995; Hermans, Pieters, & Elen, 1998), and are
free of the bias sometimes present in introspective reports of cognitive processes (Nisbett &
Wilson, 1977). The emotional Stroop task may therefore represent a valid means of measuring
withdrawal-related urge/craving.
It is important to note that there are different formats in which the emotional Stroop task
can be administered (see Waters & Feyerabend, 2000, and Waters, Sayette, & Wertz, 2003). In
many experiments, colored words are presented on cards, and there is one card for each set of
semantically related words. For example, Gross et al. (1993) presented smoking-related words on
one card and neutral words on another. The difference in color-naming times for the smokingrelated versus the neutral card provided the measure of attentional bias. Similarly, with computer
presentation, words can be presented in separate groups of similar meaning (e.g., Johnsen et al.,
1997; Waters, Shiffman, et al., 2003). This manner of administration is known as the “blocked”
format. Conversely, in other experiments, words are presented in a randomized series (e.g.,
Wertz & Sayette, 2001). This manner of administration is known as the “unblocked” format. It
has been suggested that these two formats may not be equivalent measures (Waters, Sayette, &
Wertz, 2003). In fact, numerous studies have reported that Stroop effects present in a blocked
administration can virtually disappear in an unblocked administration (e.g., Waters &
Feyerabend, 2000). Briefly, it has been demonstrated that exposure to smoking-related words in
an unblocked format results in a reliable carry-over effect (Waters, Sayette, & Wertz, 2003).
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Specifically, participants take longer to color-name neutral words that follow smoking-related
words, thus reducing the size of the Stroop effect. Although significant Stroop effects have been
detected in unblocked designs (e.g., Wertz & Sayette, 2001), the evidence suggests that the
blocked administration possesses more power to detect attentional bias.
Withdrawal and Relapse
Withdrawal is believed to play a central role in relapse to cigarette use (Hughes, Higgins,
& Bickel, 1994) and is frequently cited as the primary context in which relapse occurs (Benowitz,
1991). Although smokers themselves report that withdrawal symptoms are obstacles to
abstinence (Cummings, Jaen, & Giovino, 1985), several findings challenge the assumption that
withdrawal plays a causal role in relapse. Whereas some research suggests that smokers with
more severe abstinence-induced urge (Garvey, Bliss, & Ward, 1990; Gritz, Carr, & Marcus,
1991; Killen et al., 1992; West, Hajek, & Belcher, 1989) and depression (Covey, Glassman, &
Stetner, 1990; Hughes, 1992b) are more likely to relapse, other studies indicate that withdrawal is
inconsistently related to relapse (e.g., Brandon, Tiffany, Obremski, & Baker, 1990; Breslau,
Kilbey, & Andreski, 1992; Hall, Havassy, & Wasserman, 1990; Hughes, 1993; Jorenby et al.,
1995; Kenford et al., 1994; Patten & Martin, 1996) as well as to other measures of dependence
(Hatsukami, Hughes, & Pickens, 1985; Hughes, 1992b).
Piasecki et al. (1998, 2000, 2003a, 2003b), in a series of landmark studies, attempted to
reconcile the theoretical importance of withdrawal with its insufficient empirical support. The
authors noted two critical flaws within previous studies of withdrawal-relapse relations. First,
most studies attempted to represent withdrawal scores with single-occasion assessment
“snapshots” in prediction models. However, because withdrawal is essentially a measure of
negative affect, and affect can be influenced by a host of nonpharmacologic factors, the time
course of withdrawal should vary from person to person. Traditional data-analytic techniques
could not account for the idiosyncratic nature of withdrawal. Second, the majority of studies
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limited analyses to those individuals who achieved complete abstinence during the period of
withdrawal assessment. This exclusion bias may have further inhibited the detection of true
withdrawal-relapse relations. For these reasons, the authors employed cluster analyses and
hierarchical linear growth models with both lapsing and continually abstinent smokers to identify
independent groups of individuals with distinct temporal patterns of withdrawal symptoms.
Consistent with their hypotheses, they found groups of participants with unique models of
symptomatology. Furthermore, they found that the severity, duration, and shape of withdrawal
significantly predicted relapse to smoking. Specifically, those who experienced more severe,
longer lasting, and unsystematic (e.g., late elevations) symptoms were more likely to relapse.
These studies provided strong evidence that, consistent with theoretical predictions, withdrawal
plays a critical role in cigarette use. They further supported the notion that avoidance of negative
affect is the motivational basis of cigarette smoking, although negative affect need not be caused
solely by the absence of nicotine in the nervous system. That is, withdrawal may be
conceptualized as both the readaptation of the nervous system to the absence of nicotine in the
body and the readaptation of the individual to coping with negative affect without the use of
cigarettes (see Baker, Piper, et al., 2004, and Piasecki & Baker, 2000).
The Onset of Withdrawal
Despite the large volume of research on smoking withdrawal, there is a paucity of data
concerning the early time course of symptoms. The vast majority of studies have focused on the
onset and remission of symptoms over the course of several days and weeks (e.g., Gross &
Stitzer, 1989; Hughes, 1992b; Hughes et al., 1991) with the earliest assessment periods occurring
the day after cessation (e.g., Piasecki et al., 1998, 2000, 2003a, 2003b, 2003c). (However, in one
study [Killen et al., 2001], withdrawal was measured after eight hours of abstinence). Indeed,
there appears to be some confusion regarding the onset of withdrawal, as published studies have
reported inconsistent information regarding the emergence of symptoms. For example, Shiffman
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et al. (2002) stated that withdrawal starts to emerge two hours postcessation, whereas Hughes,
Higgins, and Bickel (1994) reported that symptoms begin between six and 12 hours after the last
cigarette. Neither of the authors offered empirical support for their assertions.
Although very few data directly address acute withdrawal, a small body of research exists
upon which one might infer its temporal characteristics. To the extent that withdrawal reflects
declining levels of nicotine in the body, some symptoms of withdrawal are likely to emerge
relatively rapidly after cessation, given that the distributional half-life of nicotine is about 10
minutes. This expresses the time it takes a nicotine dose to fall 50% from its peak level in the
brain as it is distributed to other parts of the body (Russell, 1988). Nicotine’s terminal half-life,
which refers to the time it takes a dose to fall 50% from its highest level in the body, is
approximately two hours (e.g., Benowitz, 1998; Gilbert, 1995). Thus, even conservative
estimates might place the onset of withdrawal within the first two hours after last smoking.
Consistent with this notion, Hatsukami, Pickens, Svikis, and Hughes (1988) observed that the
typical interval of ad lib smoking in the natural environment is just under 40 minutes.
A handful of experimental data offer further insight regarding the emergence of
withdrawal symptoms. Tiffany and Drobes (1991), in the development of the QSU, administered
the QSU and the WSC to smokers who abstained for zero, one, or six hours. Participants reported
stronger urges to smoke on the QSU and more intense ratings on the Craving and Psychological
Discomfort subscales of the WSC one hour after smoking, relative to those who completed the
measures immediately after their last cigarette. Those who abstained for six hours reported
stronger urges on the QSU and more intense ratings on the Craving and Psychological Discomfort
scales of the WSC relative to those who abstained for one hour. These results suggest that some
withdrawal symptoms begin to emerge within one hour postcessation and increase over the
following few hours. However, because measurements occurred only at zero, one, and six hours,
the precise time course of withdrawal cannot be determined from this study. Furthermore,
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because assessment measures consisted only of an urge inventory and a self-report withdrawal
questionnaire with problematic psychometric properties (see Welsch et al., 1999), the onset and
time course of the full range of withdrawal symptoms is uncertain.
Schuh and Stitzer (1995), in a study of desire to smoke and its relationship to smoking
behavior, assessed urge on a four-item questionnaire. In a within-subjects design, participants
smoked every 30 minutes, 60 minutes, 120 minutes, or remained abstinent during a six-hour
period. The investigators measured urge immediately after smoking (baseline), followed by
assessment periods at 15-minute intervals. They found that urge to smoke increased from
baseline 15 minutes after smoking and increased to almost maximum levels after less than three
hours of abstinence. This is roughly consistent with information regarding the distributional and
terminal half-life of nicotine. Although revealing, this study was limited by its small sample size
(N = 10) and by the lack of a standard measure of smoking urge. Furthermore, because this study
assessed only one aspect of withdrawal, little can be inferred regarding the initial time course of
the complete withdrawal syndrome.
In a similar study, Gross, Lee, and Stitzer (1997) examined the effect of nicotinecontaining versus de-nicotinized cigarettes on craving and withdrawal. Participants smoked their
own brand of cigarette, a standard nicotine-containing cigarette, or a de-nicotinized cigarette.
Urge was assessed on a 4-item questionnaire immediately after smoking (baseline) and then at
15-minute intervals during a 90-minute deprivation period. At the end of the 90-minute period,
withdrawal was assessed using the MNWS. Consistent with the findings of Schuh and Stitzer
(1995), the authors found that urge ratings significantly increased 15 minutes after last smoking
for each type of cigarette. Furthermore, the researchers found that eight of the 11 items of
MNWS significantly increased across conditions. Specifically, participants reported increased
urge to smoke, craving for cigarettes/nicotine, irritability, anxiety, difficulty concentrating,
restlessness, impatience, and hunger. These findings are generally consistent with those of
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Tiffany and Drobes (1991) and suggest that multiple symptoms of withdrawal begin to emerge
within 90 minutes after last smoking. This study was nevertheless limited by its small sample
size (N = 10) and by the fact that withdrawal was assessed only at baseline and 90-minutes
postcessation. Due to these limitations, the early time course of withdrawal remains an open
question.
A small number of studies offer insight concerning the emergence of withdrawal-related
attentional difficulties. Hatsukami et al. (1989) measured cognitive performance on a battery of
tasks in smokers who were abstinent for zero, two, four, eight, or 24 hours. Those who were
abstinent for four hours scored significantly worse on a trail making task compared to those who
completed the battery immediately after smoking. However, no other significant short-term (i.e.,
less than 24 hours) differences were found. In a similar study, Snyder et al. (1989) administered a
computerized test battery to abstinent smokers at one, four, eight, and 24-hour intervals.
Performance deficits first emerged on the digit recall and two-letter search task after four hours of
abstinence. Mancuso, Warburton et al. (1999) administered measures of attention to smokers
who remained abstinent for either three or six hours. Participants completed the tasks while
wearing either the placebo or active patch. Whereas no differences in performance were found
after three hours, those who received the placebo patch performed significantly worse on the
random letter generation task and the original Stroop task than those who received the active
patch after six hours. Taken together, these studies suggest that deficits in attentional processing
may begin to emerge between three and four hours postcessation. However, given that certain
cognitive tests may be more sensitive to the effects of withdrawal than others (Bell et al., 1999), it
cannot be determined if the tasks employed by the three investigations were adequately sensitive
to detect the onset of attentional impairment. Indeed, given that none of the studies employed
measures that have produced consistent findings in the smoking literature (e.g., the RVIP), it is
possible that withdrawal-related impairment emerges at an earlier time.
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Warburton and Arnall (1994) examined the effects of smoking abstinence on RVIP
performance. Participants remained abstinent for one hour and then completed the RVIP.
Following completion of the task, participants smoked a cigarette, and then completed the RVIP
for a second time. Smokers displayed faster reaction times and more correct responses
immediately after smoking, relative to one hour of abstinence. Pritchard, Robinson, and Guy
(1992) investigated smokers’ performance on a continuous performance task similar to the RVIP.
The authors found that those who smoked immediately before completing the task displayed
faster reaction times than those who remained abstinent for 15 minutes before task completion. A
possible explanation of these findings (i.e., Heishman et al., 1994) is that smoking reversed a
withdrawal-related attentional deficit that emerged at one hour/15 minutes after last smoking
(however, both authors argued that those who had been abstinent for one hour/15 minutes
experienced minimal or no withdrawal and therefore smoking had produced an absolute
facilitation of performance). Nevertheless, two critical flaws of these studies limit the
generalizability of their findings. First, although participants abstained from smoking for the first
hour/15 minutes of the experiments, participants’ time since smoking their last cigarette before
the studies was not determined. The precise abstinence intervals are therefore unknown. Second,
because baseline assessments were not conducted, the degree to which reaction times may have
changed after one hour/15 minutes of abstinence cannot be determined. Still, these studies
suggest that withdrawal-related attentional difficulties may emerge around the same time as selfreported withdrawal symptoms.
It is important to determine the early time course of smoking withdrawal. Such
information will fill a gap in the research literature and provide a more complete understanding of
a critical construct to smoking behavior. Furthermore, it will provide important insight regarding
smokers’ moment-to-moment motivation for cigarette use. Finally, this information may have
significant implications for the treatment of smoking. For example, pharmacotherapies may
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require modification to properly alleviate initial withdrawal. Moreover, smoking cessation
counseling may potentially improve its ability to help smokers prepare for the aversive symptoms
following the cessation of cigarette use.
The Current Study
The main objective of the current study was to conduct a comprehensive, multimodal
assessment of the early time course of the symptoms associated with smoking withdrawal. This
goal required unique consideration because no previous studies have examined the early temporal
characteristics of smoking withdrawal. Indeed, there is no standard means for assessing
symptoms over succinct periods of time.
Participants were smokers randomly assigned to either be abstinent or smoke at their own
pace for four hours. All participants were instructed to smoke at their own pace at the beginning
of the study. Baseline withdrawal assessment then occurred, followed by withdrawal symptom
assessments every 30 minutes, for a total of nine assessments.
Withdrawal symptoms were assessed with a physiological measure of heart rate, the
RVIP, an emotional Stroop task, and the WSWS. We expected abstinent participants to exhibit
greater withdrawal, as indexed by greater mean withdrawal or a greater rate of increasing
withdrawal over time (i.e., withdrawal slope). Given previous findings (e.g., Gross, Lee, &
Stitzer, 1997; Pritchard, Robinson, & Guy, 1992; Tiffany & Drobes, 1991; Schuh & Stitzer,
1995; Warburton & Arnall, 1994) and a distributional half-life of nicotine of 10 minutes, it was
hypothesized that these differences would begin to emerge at the first post-baseline assessment,
i.e., at 30 minutes postcessation.
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Method
Participants
Participants were 50 individuals recruited from the local community through newspaper
advertisements and fliers. Participants were required to 1) speak English, 2) have a breath carbon
monoxide (CO) of at least 10 ppm, 3) report a smoking rate of at least 20 cigarettes per day for at
least the past year, 4) have not been attending a formal treatment program, 5) have not been using
any form of pharmacotherapy for smoking cessation, and 6) have not been trying to quit.
Moreover, to control for age-related decrements in the Stroop task and sustained attention (e.g.,
Braver et al., 2001), participants must have been between 18 and 45 years of age. Participants
received $15.00 per hour of participation. As an additional incentive, participants were entered in
a raffle for an additional $50.00 upon the completion of their participation.
Intake Measures
Demographic Questionnaire. Single items assessed participants' age, education, marital
status, ethnicity, occupation, and income (See Appendix A).
Drinking Information Questionnaire. Participants were asked to indicate, on average,
how many days they drank alcohol per month (occasions/month) and how many standard drinks
they typically drank on occasions when they did drink (drinks/occasion; the definition of a
standard drink was provided). Drinks per month was calculated using these two questions. Selfreport data using similar questions have been shown to be valid measures of drinking behavior
(Babor, Brown, & Del Boca, 1990; Del Boca & Darkes, 2003). This brief screening
questionnaire was used to infer group equivalence with regard to potential alcohol withdrawal
that could affect participants’ experience of smoking-related withdrawal symptoms (See
Appendix B).
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Caffeine Consumption Questionnaire. Following the procedure of previous research
(e.g., Gilbert, Dibb, Plath, & Hiyane, 2000), participants were asked to indicate, on average, how
many caffeinated beverages they consume per day. One cup of caffeinated coffee was assumed
to contain approximately 75 mg of caffeine, and one standard serving of caffeinated tea or soft
drink was assumed to contain approximately 30 mg of caffeine. This brief screening
questionnaire was used to infer group equivalence with regard to the potential effect of caffeine
intake on heart rate, RVIP performance, and negative affect (e.g., Gilbert et al., 2000) (See
Appendix C).
Smoking Status Questionnaire. This form was used to assess smoking status and nicotine
dependence. The Smoking Status Questionnaire includes the Fagerström Test for Nicotine
Dependence, a reliable and valid measure of nicotine dependence (FTND; Heatherton,
Kozlowski, Frecker, & Fagerström, 1991) (See Appendix D).
Smoking Consequences Questionnaire-Adult (SCQ-A; Copeland, Brandon, & Quinn,
1995). The standard instrument for measuring smoking expectancies in experienced smokers, the
SCQ-A measures outcome expectancies on 10 factors. Coefficient alpha reliabilities for the 10
scales range from .83 to .96. The scale scores on the SCQ-A have been shown to distinguish
among smokers of varying smoking patterns and levels of nicotine dependence, and to predict
cessation outcome (Copeland et al., 1995) (See Appendix E).
Contemplation Ladder (Biener & Abrams, 1991). The Contemplation Ladder is a
continuous measure of intention to quit smoking. It has been compared to other readiness to quit
measures and has been established as a valid predictor of smoking cessation (Biener & Abrams,
1991; Herzog, Abrams, Emmons, & Linnan, 2000) (See Appendix F).
Stages of Change Questionnaire (Prochaska & DiClemente, 1983). The Stages of Change
Questionnaire is a 3-item measure of motivation to quit smoking. This measure is predictive of
quit attempts and cessation (DiClemente et al., 1991). Although the Stages of Change
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Questionnaire lacks some of the psychometric advantages of the Contemplation Ladder (Herzog,
Abrams, Emmons, & Linnan, 2000), it is widely used, and its inclusion allows for comparisons
with other published research (See Appendix G).
Positive and Negative Affect Schedule (PANAS; Watson, Clark, & Tellegen, 1988).
Scores on the Negative subscale of the PANAS (i.e., the NPANAS) were used as predictors of
withdrawal. This reliable and valid measure of negative affect has been shown to significantly
predict mean withdrawal severity (Piasecki et al., 2003c) and track withdrawal (Piasecki et al.,
1998) across eight weeks of abstinence. Furthermore, NPANAS scores have been shown to
predict withdrawal elevation across four weeks of abstinence (Piasecki et al., 2000), and are
powerful predictors of relapse (Kenford et al., 2002) (See Appendix H).
Withdrawal Measures
Heart rate. Heart rate was assessed using a Coulbourn bioamplifier with bandpass filter
(model V75-01). High pass filter was set at eight Hz and low pass filter was set at 40 Hz.
Electrodes were attached according to established guidelines; one large (8mm) electrode filled
with saline electrode gel was placed on each forearm, and one ground electrode was also placed
on the non-dominant forearm. Heart rate was measured by the detection of inter-beat intervals
using a Schmitt trigger set to identify the R-wave within each cardiac cycle. A computer, located
in an adjoining room with the Coulbourn bioamplifier, controlled assessment times. Heart rate
data were directly inputted into this computer.
Rapid Visual Information Processing task (RVIP; Wesnes & Warburton, 1983). A
computer located in the experimental room controlled RVIP administration using SuperLab Pro
experimental laboratory software. A series of single digits appeared in the center of the computer
screen in 200-point Times New Roman font at a rate of 100 digits per minute. Because previous
research revealed that the RVIP distinguished between abstinent and non-abstinent smokers
within the first four minutes of the task (see Herbert, Foulds, & Fife-Schaw, 2001), total
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administration time was four minutes. Participants were instructed to press a response button as
quickly as possible whenever they noticed three consecutive odd or even digits. To control for
practice effects, each RVIP task was unique across repeated administrations. However, for each
administration, response targets appeared eight times per minute, with five to 30 digits appearing
between each target. Response windows (i.e., the time during which participants’ responses were
recorded) lasted 1500 milliseconds. Reaction time to targets and errors of omission (i.e., miss
rate) and commission (i.e., false hit rate) were recorded by the computer.
Emotional Stroop task. A computer located in the experimental room controlled
emotional Stroop task administration using SuperLab Pro experimental laboratory software.
Following the procedure of previous research (e.g., Waters, Shiffman, et al., 2003), words were
presented on the computer screen one at a time in one of three colors (red, blue, or green).
Participants were instructed to indicate the color of each word as quickly and as accurately as
possible while ignoring its meaning by pressing one of three response buttons: a button marked
by the letter “r” for red, a button marked by the letter “b” for blue, and a button marked by the
letter “g” for green. Prior to baseline assessment, participants responded to a practice sequence of
letter strings (e.g., ABCD). During assessment periods, participants responded to neutral and
smoking-related words. Neutral words were presented in a blocked format before smokingrelated words so that they were not affected by any carryover effect that can occur with such
Stroop tasks (cf. Waters, Sayette, & Wertz, 2003). Smoking-related words were then presented in
blocked format.
The following instructions appeared on the computer screen before each emotional
Stroop task administration: “Press the ‘b’ button to begin.” The first neutral word appeared five
seconds after participants pressed the “b” button. Each word remained on the screen until the
participant pressed a button; however, if the participant made no response, the word was removed
after three seconds. A 500-millisecond interval separated each word, and a five-second interval
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separated the neutral and smoking-related blocks. Each word was presented in the center of the
screen, in capital letters, and in 40-point Time New Roman font. Participants were instructed to
use their dominant hand and answer with their index finger only. Moreover, participants were
instructed to begin the task with their index finger on a black dot just below the three response
buttons, and after each time they responded, to return their index finger to the black dot.
Smoking-related words included 11 words used by Waters, Shiffman, et al. (2003).
These words were TOBACCO, CIGARETTE, SMOKE, ASHTRAY, PACK, PUFF, DRAG,
INHALATION, NICOTINE, CRAVING, and URGE. Smoking-related words also included 11
free associates to the words used by Waters, Shiffman, et al. (2003) according the University of
South Florida Word Association, Rhyme, and Word Fragment Norms (Nelson, McEvoy, &
Schreiber, 1998). These words are SMOKING, LIGHTER, ASH, BUTT, CAMEL, CARTON,
LIT, MATCH, BURN, TAR, and MENTHOL. Each smoking-related word was matched to a
neutral word for length and frequency of use in the English language according to Kučera and
Francis (1967). These neutral words (with corresponding smoking-related words in parentheses)
were COTTAGE (tobacco), DETERGENT (cigarette), TEACH (smoke), FREEZER (ashtray),
STAR (pack), KITE (puff), ROPE (drag), HELICOPTER (inhalation), BRACELET (nicotine),
SHAMPOO (craving), CURL (urge), DIAMOND (smoking), RAILWAY (lighter), BEE (ash),
SILK (butt), ROBOT (camel), HOCKEY (carton), GAP (lit), QUEEN (match), LAWN (burn),
EGG (tar), and INFLATE (menthol).
The standard approach to administering the Stroop task entails presenting each
pathology-related and neutral word once in each of the colors being used (cf. Waters, Shiffman, et
al., 2003). Mean reaction time for all pathology-related words is then compared to mean reaction
time for all neutral words. Thus, if the standard approach were computed for the current study,
each of the 22 smoking-related and neutral words would appear once in each of the three colors,
for a total of 66 smoking-related trials and 66 neutral trials.
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An alternative to the standard Stroop task entails comparing mean reaction time for the
first subblock of pathology-related words (e.g., the first 11 smoking-related words) to mean
reaction time for the neutral words. This index is known as the “acute Stroop.” Evidence
suggests that the acute Stroop index is the most powerful measure of attentional bias, perhaps
because it captures participants’ attentional bias before they habituate to the pathology-related
words (Waters & Feyerabend, 2000; Waters, Shiffman, et al., 2003). Thus, for the current study’s
emotional Stroop task, for each administration, 11 of the 22 smoking-related words and their
corresponding neutral words were presented once. Words were presented randomly within
blocks according to the following guidelines: a) the same color did not appear on two consecutive
trials, b) any given smoking-related and neutral word appeared only once within its block, and c)
to control for practice effects (e.g., repetition priming effects), each administration included less
than 40% of the smoking-related and neutral words from the previous administration. The
presentation order of colors was randomized for each administration. Mean reaction time and
error rate for each block was recorded by the computer. Although presenting each word only
once per administration may have resulted in a less reliable measure of attentional bias, the
advantages of this method of administration was thought to outweigh this potential disadvantage.
In addition to providing a strong measure of attentional bias, presenting each word only once may
have reduced the likelihood that practice effects masked Stroop interference with repeated
administration (Mogg & Bradley, 1998; Williams et al., 1996).
Wisconsin Smoking Withdrawal Scale (WSWS; Welsch et al., 1999). Participants were
administered the WSWS with instructions to complete it with reference to their current
experience. The WSWS measures withdrawal symptoms on 7 subscales: Anger, Anxiety,
Concentration, Craving, Hunger, Sadness, and Sleep. Coefficient alpha reliabilities for the 7
subscales range from .75 to .93, with the coefficient alpha for the total scale at .91. The WSWS
has been shown to predict smoking outcomes, indicating good construct validity. Because the
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WSWS was originally constructed to assess withdrawal symptoms over the course of several
hours or days, individual items were reworded so that they would assess current withdrawal
symptoms (e.g., “I have felt frustrated” to “I feel frustrated”). Furthermore, due to their
inapplicability to early withdrawal symptoms, items on the Sleep subscale (e.g., “I am satisfied
with my sleep.” and “I am getting restful sleep.”) were removed. Finally, to increase the
sensitivity of WSWS to determine differences in early withdrawal symptoms, the response scale
was expanded from the original 0-4 to 0-8 range (see Appendix I).
Procedures
Those participants who qualified were scheduled for an appointment to take place at the
Tobacco Research and Intervention Program (TRIP) at the H. Lee Moffitt Cancer Center between
the hours of noon and 9:00 pm. All participants were instructed to smoke as usual prior to their
appointment. They were told that the study involved the naturally occurring biological and
psychological states of smokers. They were further instructed that the study required the
completion of some tasks and questionnaires, and may require abstaining from smoking.
Participants were told that the study required between four and six hours of their time. Finally,
participants were instructed to bring at least one pack of their own cigarettes, or however many
were necessary for them to smoke at their usual rate for the duration of the study.
Upon their arrival at TRIP, participants were greeted and led to an experimental room.
Informed consent was obtained and smoking status was confirmed via breath carbon monoxide.
Upon confirmation of smoking status, participants completed the intake measures. Participants
then completed practice sessions of the emotional Stroop task and RVIP. Next, they were
instructed to smoke at their own pace in the experimental room and to notify the experimenter
when they were finished smoking. The purpose of this was to help to produce equivalence
among participants at baseline with regard to the experience of withdrawal symptoms. Upon
termination of cigarette use, baseline withdrawal symptom assessment occurred. Participants
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were then randomly assigned to one of two conditions, stratified by gender and cigarettes smoked
per day (above/below 30 cigarettes per day), with the use of a random number table. Prior to
study initiation, sequential numbers from this table were placed into individual envelopes to be
opened only after eligibility had been determined and consent had been given, so that researchers
were unaware of group assignment for any given participant until after the baseline assessment
for that participant had occurred. Half received instructions to smoke at their own pace
throughout the experiment, whereas the other half were asked to abstain from smoking. Because
the availability of cigarettes has been shown to affect urge (Juliano & Brandon, 1998) and
emotional Stroop performance (Wertz & Sayette, 2001), abstaining participants were not
informed when they would be allowed to smoke. Moreover, the exact duration of the experiment
was not disclosed so that abstaining participants were not able to anticipate smoking availability.
Abstaining participants’ cigarettes were collected following randomization and were returned at
the conclusion of the study.
Those who received instructions to smoke at their own pace did so in an experimental
room properly equipped to ventilate cigarette smoke. They were told that they could smoke at
any time during the study with the exception of assessment periods. To encourage ad lib
smoking, those participants who abstained from smoking during any interassessment interval
were asked to light and take at least one puff from one of their cigarettes during the following
interassessment interval. The number of cigarettes participants smoked between assessments was
determined by counting cigarette butts. If participants did not smoke an entire cigarette (e.g., if
they had to terminate smoking to begin the completion of withdrawal measures), the proportion
of the cigarette that was smoked was estimated.
Withdrawal assessments occurred at 30-minute intervals over four hours following
baseline assessment. Assessment measures were administered in the following order: heart rate,
the RVIP, the emotional Stroop task, and the WSWS. Heart rate assessments took place first to
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control for any physiological reactivity that may have occurred during the completion of the other
measures. The RVIP was then completed so that fatigue was minimal at the time of
administration. The emotional Stroop task took place next to control for any priming effect of the
WSWS. The WSWS was administered last. The order of administration remained constant for
each assessment period to control for the abovementioned carryover effects, and to provide for
constant intervals between assessment periods for the duration of the study. CO assessments
occurred at the conclusion of each withdrawal assessment to provide an objective measure of
participants’ smoking behavior. Between assessments, participants had the opportunity to read a
variety of magazines free of smoking-related images. Table 1 summarizes the procedure of the
study.
Table 1
Summary of Procedure
Event
Informed consent, intake measures, Stroop and RVIP practice sessions
Smoking period
Baseline assessment
Randomization to smoking/abstaining condition
Assessment 1
Assessment 2
Assessment 3
Assessment 4
Assessment 5
Assessment 6
Assessment 7
Assessment 8

Interval

min. 0-10
min. 30-40
min. 60-70
min. 90-80
min. 120-130
min. 150-160
min 180-190
min. 210-220
min. 240-250

Upon completion of the study, participants were debriefed and paid for their
participation.
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Results
Analysis Strategy. The following analysis strategy was used for CO and each measure of
withdrawal. First, a one-way ANOVA was conducted at baseline to determine equivalence
between the two groups with regard to baseline values. Generalized Estimating Equations
(GEEs) were then employed to determine group differences in withdrawal symptom severity
across assessment periods. Proposed by Liang and Zeger (1986), GEEs are an extension of the
generalized linear model approach (McCullagh & Nelder, 1989). They are appropriate for the
analysis of longitudinal data, and have advantages over alternative methods of longitudinal data
analysis (Davidian & Giltinan, 1995). Specifically, GEEs are robust to violations of normality,
allow for correlations among repeated measurements on the same participant, and can account for
both linear and nonlinear data (Davidian & Giltinan, 1995).
Two types of GEE models were conducted: main effect model GEEs, and interaction
effect (i.e., slope) model GEEs. These two models were employed separately because main
effects and interaction effects cannot be examined simultaneously with GEEs.
Main effect model GEEs were conducted with group and time entered as independent
variables. A significant GEE group estimate indicated that, across all post-baseline (30-240 min)
time points, the two groups displayed significantly different means. Significant group estimates
with positive values indicated that the abstinent group displayed a greater magnitude of the
measure over time, whereas significant group estimates with negative values indicated that the
abstinent group displayed a lesser degree of the measure over time.
Interaction model GEEs were conducted with group, time, and a group by time
interaction term entered as independent variables. In this case, the only estimate of concern was
that of the interaction term (significant group terms are not indicative of a main effect in
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interaction model GEEs). A significant GEE interaction estimate indicated that, across all time
points, the two groups displayed significantly different slopes. Generally speaking, significant
interaction estimates with positive values indicated that the abstinent group exhibited an increase
in the measure over time relative to the smoking group, whereas significant group estimates with
negative values indicated that the abstinent group exhibited a decrease in the measure over time
relative to the smoking group. Ultimately, however, data graphs must be examined to determine
the nature of the slope difference.
If the main effect model GEE revealed a main effect of group, a post hoc analysis was
conducted to determine the onset of mean difference between the two experimental conditions.
Specifically, a one-way ANOVA was conducted at 30 minutes, followed by a progressive series
of main effect model GEEs between 30 minutes and subsequent time points (i.e., between 30
minutes and 60 minutes, 30 minutes and 90 minutes, 30 minutes and 120 minutes, etc.). Baseline
was not incorporated into main effect analyses because participants in neither group were
abstaining at this point, and the two groups were equivalent at baseline on all measures of
withdrawal.
If the interaction model GEE revealed a difference in slope between the two groups, a
progressive series of interaction model GEEs were conducted between baseline and subsequent
time points to determine the point at which the slopes for the two groups began to differ
significantly. Baseline scores were included in this case because change over time was the focus
of the analysis.
Preliminary Analyses
A complete summary of participants’ demographic and smoking history characteristics is
presented in Table 2. A series of one-way analyses of variance (ANOVAs) and chi-square
analyses (for categorical variables) indicated that the groups were equivalent on all demographic
and smoking history variables (all p’s > .20).
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A complete summary of potential moderator variables is presented in Table 3. A series
of ANOVAs and chi-square analyses indicated that the groups were equivalent on all of these
variables (all p’s > .07). In addition, the two groups were equivalent on self-reported caffeine
consumption, F (1,48) = 1.05, p = .31, and alcohol consumption F (1,48) = .001, p = .97.
Manipulation Check: Smoking Behavior and CO
On average, participants in both the abstinent group (M = 1.1, SD = .28) and smoking
group (M = 1.1, SD = .46) smoked an equal number of cigarettes at baseline. Whereas
participants in the abstinent condition, as instructed, smoked no cigarettes during interassessment
intervals, participants in the smoking condition smoked a mean of approximately one cigarette at
each interassessment interval (M = .80, SD = .4).
Figure 1 summarizes breath CO ppm across assessment period time points. A one-way
ANOVA indicated that the abstinent group and the smoking group exhibited equivalent CO at
baseline, F (1, 48) = .003, p = .956. However, as expected, a GEE revealed a main effect of
group membership across subsequent assessment periods. Specifically, the abstinent group
exhibited an overall lower CO than the smoking group,  = -12.32, p = .003. A GEE further
revealed an interaction between group membership and time. Specifically, whereas CO
decreased across time for the abstinent group, CO increased across time for the smoking group, B
= -2.98, p < .0001.
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Table 2
Demographic and Smoking Characteristics
Experimental Condition
Total
Abstinent
Smoking
Characteristic
(N = 50)
(N = 25)
(N = 25)
________________________________________________________________________
Demographics
% Female
58
60
56
Age
M
29.2
29.24
29.16
SD
8.31
8.86
7.90
Education
%Some high school
14
12
16
%High school degree
16
20
12
%Business/Tech degree
14
12
16
%Some college
48
44
52
%University degree
8
12
4
Annual household income
Median
$20,000
$15,000
$25,000
Marital Status
%Single
78
72
84
%Married
12
12
12
%Separated
4
8
0
%Divorced
6
8
4
Race
%White
80
72
88
%African American
12
12
12
%More than one race
6
12
0
%Other
2
4
0
%Hispanic (any race)
6
8
4
Smoking History
Cigarettes per day
M
23.54
23.50
23.58
SD
4.75
4.62
4.97
Years Smoking Daily
M
12.85
13.26
12.44
SD
8.07
8.32
7.97
Mean Fagerström Score
M
5.42
5.48
5.36
SD
1.92
1.38
2.37
Intake CO
M
27.62
26.68
28.56
SD
16.00
13.84
18.15
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Table 3
Exploratory Moderator Variables
Experimental Condition
Abstinent
Smoking
(N = 25)
(N = 25)

Total
Characteristic
(N = 50)
Contemplation Ladder
M
5.38
SD
1.92
Stages of Change
%Precontemplation
52
%Contemplation
36
%Preparation
12
NPANAS
M
14.54
SD
4.54
SCQ-A
Negative Affect Reduction
M
6.94
SD
1.51
Stimulation/State Enhancement
M
3.72
SD
1.84
Health Risk
M
8.57
SD
.82
Taste/Sensorimotor Manipulation
M
4.84
SD
2.11
Social Facilitation
M
4.76
SD
1.99
Weight Control
M
3.74
SD
2.73
Craving/Addiction
M
7.19
SD
1.09
Negative Physical Feelings
M
3.87
SD
2.07
Boredom Reduction
M
6.45
SD
2.23
Negative Social Impression
M
4.76
SD
2.40
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4.92
2.58

5.84
2.19

48
48
4

56
24
25

15.72
5.23

13.36
3.45

7.14
1.41

6.74
1.61

3.91
2.21

3.53
1.40

8.59
.90

8.55
.74

4.60
2.19

5.06
2.04

4.91
2.14

4.61
1.85

4.34
3.04

3.13
2.29

7.20
.99

7.19
1.21

4.33
2.12

3.41
1.97

6.27
2.60

6.63
1.81

4.92
2.17

4.60
2.65

Figure 1
Carbon Monoxide (CO) in ppm across Assessment Periods
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Note. Error bars are +/- 1 SEM.
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Withdrawal Measures
Heart rate. Figure 2 summarizes participant heart rate in beats per minute (bpm) across
assessment period time points and Table 4 presents GEE parameter estimates for both the main
effect and interaction models. It was hypothesized that abstinent participants would display lower
mean heart rate or a greater degree of decreasing heart rate across assessment periods. This
hypothesis was supported. A one-way ANOVA indicated that the abstinent group and the
smoking group displayed equivalent heart rate at baseline, F (1,48) = .89, p = .35. A GEE
revealed no main effect of group membership across subsequent assessment periods, but there
was a main effect of time; heart rate for both groups significantly decreased across assessment
periods. As hypothesized, a GEE revealed a significant interaction between group membership
and time. Specifically, although heart rate decreased for both groups across assessment periods,
this decrease was more pronounced in the abstinent group. Post hoc analysis indicated that
abstinent group began to display a significantly steeper slope than the smoking group between
baseline and 60 minutes postcessation,  = -2.61, p = .01.
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Figure 2
Heart Rate in bpm across Assessment Periods
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Note. Error bars are +/- 1 SEM.
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Table 4
Heart Rate GEE Parameter Estimates
Main Effect Model
Parameter

Estimate

SE

95% CI

P-value

Intercept

84.86

2.32

80.31 to 89.41

<.0001

Group

-2.35

2.81

-7.87 to 3.17

.40

Time

-1.62

.19

-2.00 to –1.23

<.0001

Interaction Model
Parameter

Estimate

SE

95% CI

P-value

Intercept

81.79

2.43

77.02 to 86.56

<.0001

Group

3.88

3.35

-2.68 to 10.46

.25

Time

-.99

.26

-1.51 to -.48

.0001

Group X Time

-1.24

.35

-1.94 to -.55

.0004

Note. Working correlation for both models = Auto-regression (AR1).
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RVIP. Elimination of outliers with reaction time data is considered optimal for obtaining
valid results (Ratcliff, 1993). Outlying RVIP data were therefore removed prior to analysis in
two steps. First, within each participant’s individual RVIP administrations, responses to targets
that were beyond two standard deviations above or below the mean for that participant’s specific
administration were removed. Second, within each experimental group, individual participant
means for each administration that were beyond two standard deviations above or below the mean
for that group’s administration were removed. This resulted in the removal of 28 individual
participant means (of 450; 6.2%).
Figure 3 summarizes participant RVIP reaction time in milliseconds across assessment
period time points and Table 5 presents GEE parameter estimates for both the main effect and
interaction models. It was hypothesized that abstinent participants would exhibit poorer sustained
attention, as indicated by higher mean RVIP reaction time or a greater rate of increasing reaction
time across assessments. This hypothesis was supported. A one-way ANOVA indicated that the
abstinent group and the smoking group displayed equivalent reaction time at baseline, F (1,44) =
.107, p = .74. As hypothesized, a GEE revealed a main effect of group membership across
subsequent assessment periods. Specifically, the abstinent group exhibited an overall slower
reaction time than the smoking group. A GEE indicated no significant interaction between group
membership and time. This indicates the group difference emerged immediately and remained
relatively constant. Post hoc analysis indicated that the abstinent group began to display a
significantly slower reaction time than the smoking group at 30 minutes postcessation, F (1, 44) =
10.32, p = .002.
In addition to reaction time, we hypothesized that abstinent participants would make
more errors (both omission and commission) on the RVIP and/or display a greater rate of
increasing errors across time. This hypothesis was not supported. GEEs revealed no significant
main effects or interactions.
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Figure 3
RVIP Reaction Time in ms across Assessment Periods

540.00

abstinent
smoking

520.00

RVIP Reaction Time

500.00

480.00

460.00

440.00

420.00
baseline

30 min

60 min

90 min

120 min

150 min

180 min

Assessment Period
Note. Error bars are +/- 1 SEM.

37

210 min

240 min

Table 5
RVIP Reaction Time GEE Parameter Estimates
Main Effect Model
Parameter

Estimate

SE

95% CI

P-value

Intercept

472.27

13.13

446.53 to 498.00

<.0001

Group

31.70

15.95

.43 to 62.98

.04

Time

-.98

1.61

-4.14 to 2.18

.54

Interaction Model
Parameter

Estimate

SE

95% CI

P-value

Intercept

470.22

14.35

442.09 to 498.35

<.0001

Group

35.65

21.14

-5.78 to 77.10

.09

Time

-.57

2.31

-5.11 to 3.95

.80

Group X Time

-.79

3.22

-7.11 to 5.53

.80

Note. Working correlation for both models = Auto-regression (AR1).
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Emotional Stroop task. Outlying Stroop task data were removed prior to analysis in two
steps. First, within each participant’s individual Stroop task administrations, responses to neutral
words that were beyond two standard deviations above or below the mean for neutral words for
that participant’s specific administration were removed. Moreover, within each participant’s
individual Stroop task administrations, responses to smoking-related words that were beyond two
standard deviations above or below the mean for smoking-related words for that participant’s
specific administration were removed. Stroop effects were then computed. Second, within each
experimental group, individual participant Stroop effect means for each administration that were
beyond two standard deviations above or below the mean for that group’s administration were
removed. This resulted in the removal of 26 individual participant means (5.8%).
Data were analyzed to determine if, consistent with previous research, participants in
both conditions demonstrated a significant Stroop effect across time points. As expected, onesample t-tests revealed a significant Stroop effect across time points for both the abstinent group,
t(24) = 4.92, p < .001, and the smoking group, t(24) = 4.47, p < .001.
Figure 4 summarizes Stroop effect in milliseconds across assessment period time points
and Table 6 presents GEE parameter estimates for both the main effect and interaction models. It
was hypothesized that abstinent participants would experience greater attentional bias toward
smoking-related stimuli, as indexed by higher mean Stroop effect or a greater rate of increasing
Stroop effect over time. This hypothesis was not supported. A one-way ANOVA indicated that
the abstinent group and the smoking group displayed equivalent Stroop effects at baseline, F
(1,45) = .658, p = .42. GEEs revealed no significant main effects or interactions.
It was further hypothesized that abstinent participants would display higher mean error Stroop
effect (errors on smoking words minus errors on neutral words) and/or a greater degree of
increasing error Stroop effect over time. This hypothesis was not supported. GEEs revealed no
significant main effects or interactions.
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Figure 4
Emotional Stroop Effect in ms across Assessment Periods
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210 min

240 min

Table 6
Emotional Stroop Effect GEE Parameter Estimates
Main Effect Model
Parameter

Estimate

SE

95% CI

P-value

Intercept

50.21

11.55

27.57 to 72.86

<.0001

Group

-2.81

8.57

-19.61 to 13.99

.74

Time

-2.98

1.80

-6.52 to .55

.09

SE

95% CI

Interaction Model
Parameter

Estimate

P-value

Intercept

42.66

13.83

15.56 to 69.77

.0020

Group

12.45

22.68

-32.00 to 56.91

.58

Time

-1.48

2.24

-5.88 to 2.91

.51

Group X Time

-3.05

3.60

-10.12 to 4.01

.40

Note. Working correlation for both models = Auto-regression (AR1).
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WSWS. Figures 5 through 10 summarize participant responses on the each of the six
subscales of the WSWS and Tables 7 through 12 present GEE parameter estimates for both the
main effect and interaction models for these subscales. For each subscale of the WSWS, it was
hypothesized that abstinent participants would report higher mean withdrawal on each subscale of
the WSWS or a greater rate of increasing withdrawal on these subscales over time. This
hypothesis was supported for each subscale with the exception of Hunger. One-way ANOVAs
indicated that the abstinent group and the smoking group reported equivalent levels of withdrawal
on each subscale of the WSWS at baseline (all p’s > .30). However, GEEs revealed a main effect
of group membership across subsequent assessment periods. Specifically, the abstinent group
reported a higher level of anger, anxiety, concentration difficulty, craving, and sadness than the
smoking group. A GEE further revealed an interaction between group membership and time.
Specifically, whereas self-reported anger, anxiety, concentration difficulty, craving, and sadness
tended to increase across time for the abstinent group, they tended to decrease or remain stable
across time for the smoking group. (In addition, the interaction approached significance (p = .09)
for the hunger scale.) Post hoc analyses revealed that the abstinent group began to display
significantly greater withdrawal at intervals ranging between 30 minutes and 180 minutes
postcessation on the various subscales of the WSWS. Table 13 summarizes post hoc analyses on
each of these scales.
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Figure 5
Self-reported Anger across Assessment Periods
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Note. Error bars are +/- 1 SEM.
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Table 7
Self-reported Anger GEE Parameter Estimates
Main Effect Model
Parameter

Estimate

SE

95% CI

P-value

Intercept

1.10

.29

.53 to 1.67

.0001

Group

1.15

.35

.46 to 1.84

.001

Time

.03

.03

-.04 to .09

.42

Interaction Model
Parameter

Estimate

SE

95% CI

P-value

Intercept

1.63

.26

1.11 to 2.15

<.0001

Group

.11

.44

-.76 to .98

.81

Time

-.07

.02

-.12 to -.03

.001

Group X Time

.21

.06

.08 to .33

.001

Note. Working correlation for both models = Auto-regression (AR1).
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Figure 6
Self-reported Anxiety across Assessment Periods
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Table 8
Self-reported Anxiety GEE Parameter Estimates
Main Effect Model
Parameter

Estimate

SE

95% CI

P-value

Intercept

2.63

.25

2.14 to 3.12

<.0001

Group

1.21

.30

.62 to 1.79

<.0001

Time

-.01

.03

-.08 to .06

.81

Interaction Model
Parameter

Estimate

SE

95% CI

P-value

Intercept

3.21

.23

2.75 to 3.67

<.0001

Group

.04

.42

-.78 to .87

.91

Time

-.12

.03

-.19 to -.05

.0003

Group X Time

.23

.06

.11 to .35

.0002

Note. Working correlation for both models = Auto-regression (AR1).
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Figure 7
Self-reported Concentration Difficulty across Assessment Periods
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Table 9
Self-reported Concentration Difficulty GEE Parameter Estimates
Main Effect Model
Parameter

Estimate

SE

95% CI

P-value

Intercept

2.19

.30

1.59 to 2.78

<.0001

Group

.87

.34

.19 to 1.55

.01

Time

.08

.03

.02 to .15

.008

Interaction Model
Parameter

Estimate

SE

95% CI

P-value

Intercept

2.57

.29

1.99 to 3.15

<.0001

Group

.10

.49

-.87 to 1.08

.84

Time

.01

.03

-.04 to .06

.74

Group X Time

.15

.06

.03 to .27

.01

Note. Working correlation for both models = Auto-regression (AR1).
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Figure 8
Self-reported Craving across Assessment Periods
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Table 10
Self-reported Craving GEE Parameter Estimates
Main Effect Model
Parameter

Estimate

SE

95% CI

P-value

Intercept

1.25

.33

.59 to 1.91

.0002

Group

2.34

.41

1.54 to 3.14

<.0001

Time

.20

.05

.10 to .31

<.0001

95% CI

P-value

Interaction Model
Parameter

Estimate

SE

Intercept

2.45

.25

1.95 to 2.95

<.0001

Group

-.07

.47

-1.00 to .86

.88

Time

-.03

.04

-.12 to .05

.44

Group X Time

.48

.08

.32 to .63

<.0001

Note. Working correlation for both models = Auto-regression (AR1).
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Figure 9
Self-reported Hunger across Assessment Periods
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Table 11
Self-reported Hunger GEE Parameter Estimates
Main Effect Model
Parameter

Estimate

SE

95% CI

P-value

Intercept

2.38

.47

1.45 to 3.29

<.0001

Group

.50

.53

-.53 to 1.54

.34

Time

.33

.04

.25 to .41

<.0001

95% CI

P-value

Interaction Model
Parameter

Estimate

SE

Intercept

2.70

.49

1.74 to 3.66

<.0001

Group

-.15

.69

-1.50 to 1.20

.83

Time

.26

.04

.17 to .35

<.0001

Group X Time

.13

.08

-.02 to .28

.09

Note. Working correlation for both models = Auto-regression (AR1)
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Figure 10
Self-reported Sadness across Assessment Periods
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Table 12
Self-reported Sadness GEE Parameter Estimates
Main Effect Model
Parameter

Estimate

SE

95% CI

P-value

Intercept

1.81

.20

1.42 to 2.21

<.0001

Group

.79

.28

.25 to 1.33

.004

Time

.01

.02

-.03 to .05

.57

Interaction Model
Parameter

Estimate

SE

95% CI

P-value

Intercept

2.09

.20

1.69 to 2.49

<.0001

Group

.23

.34

-.44 to .91

.49

Time

-.04

.02

-.09 to .01

.09

Group X Time

.11

.04

.03 to .19

.005

Note. Working correlation for both models = Auto-regression (AR1).
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Table 13
WSWS Mean and Slope Difference Onset
Mean Difference Onset

Slope Difference Onset

Anger

60 min
B = .83*

60 min
B = .36*

Anxiety

120 min
B = .85*

90 min
B = .30*

Concentration
Difficulty

180 min
B = .76*

180 min
B = .18*

Craving

30 min
F (1,48) = 5.16*

30 min
B = .89*

Sadness

150 min
B = .65*

180 min
B = .15**

Note. For mean difference onset, the time points presented are those at which one-way ANOVAs
or the progressive series of GEEs found a main effect of group; Bs are the group term parameter
estimates. For slope difference onset, the time points presented are those at which the progressive
series of GEEs first found an interaction of group by time; Bs are the group by time interaction
term parameter estimates.
* = p < .05, ** = p < .01
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Correlation Analyses
Correlation analyses were conducted to determine the intercorrelations between the
various dependent measures: heart rate, the RVIP, the Stroop effect, and each subscale of the
WSWS (scores for each measure were averaged across assessments for each participant). A
summary of these analyses is presented in Tables 14, 15, and 16. It was hypothesized that
significant correlations would exist between each of these measures. This hypothesis was largely
unsupported. However, for the abstinent group, RVIP reaction time was negatively correlated
with WSWS Craving scores. For the smoking group, RVIP reaction time was positively
correlated with heart rate. For the total sample, no significant correlations between the different
withdrawal measures were found. As expected, significant correlations were found among the
subscales of the WSWS for the abstinent group, smoking group, and total sample.
To further explore the relationship between the withdrawal measures, correlation
analyses were conducted between the measures at each of the individual assessment periods.
After controlling for multiple comparisons with a modified Bonferroni procedure, these analyses
failed to reveal significant correlations at any assessment period among measures for the
abstinent group, smoking group, and total sample. Moreover, difference from baseline scores
were created for each withdrawal measure at each assessment period. Correlation analyses were
conducted between the difference scores using both scores averaged across assessments and
scores at each of the individual assessment periods. These analyses also failed to reveal
significant correlations after controlling for multiple comparisons with a modified Bonferroni
procedure for the abstinent group, smoking group, and total sample.
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Table 14
Correlations between Withdrawal Measures: Abstinent Group

HR

RVIP

Stroop

Ang

Anx

Con

Crav

Hun

HR
RVIP

-.19

Stroop

.12

.07

Ang

-.10

-.25

.16

Anx

.10

-.13

.09

.71**

Con

-.20

-.29

-.13

.54**

.29

Crav

.31

-.41*

.08

.21

.11

.17

Hun

.21

.09

.03

-.16

-.07

-.11

.19

Sad

-.26

-.03

-.09

.62**

.66**

-.13

-.27

Note. * = p < .05, ** = p < .01
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-.19

Table 15
Correlations between Withdrawal Measures: Smoking Group

HR

RVIP

Stroop

Ang

Anx

Con

Crav

Hun

HR
RVIP

.42*

Stroop

-.14

.24

Ang

.01

.09

.19

Anx

.21

.19

-.05

.67**

Con

.13

.26

.30

.44*

.44*

Crav

.20

.13

.20

.19

.24

.54**

Hun

-.37

.18

-.09

.12

.01

-.02

-.13

Sad

-.13

.12

.26

.53**

.50*

.65**

.11

Note. * = p < .05, ** = p < .01
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.09

Table 16
Correlations between Withdrawal Measures: Total
HR

RVIP

Stroop

Ang

Anx

Con

Crav

Hun

HR
RVIP

.12

Stroop

-.02

.13

Ang

-.11

.05

.13

Anx

.07

.16

-.01

.76**

Con

-.06

.08

.08

.56**

.45**

Crav

.09

.07

.07

.44**

.43**

.46**

Hun

-.14

.16

-.04

.04

.04

-.02

.11

Sad

-.23

.14

.05

.65**

.65**

.60**

.16

Note. * = p < .05, ** = p < .01
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Moderation Analyses
Moderation analyses were highly exploratory in nature. They were conducted via GEEs
to determine the effect of gender, nicotine dependence, smoking-related expectancies, readiness
to quit, and negative affect on the relationship between experimental condition and mean
withdrawal, as well as the relationship between experimental condition and withdrawal slope.
Moderator variables were entered in a GEE one at a time for each of the withdrawal measures on
which the abstinent group differed significantly from the smoking group (either as a main effect
of group or an interaction of group by time). Analyses revealed nine significant moderators,
which was almost precisely the number expected by random probability alone. Table 17 presents
GEE parameter estimates from these results.
Table 17
GEE Moderator Analyses Parameter Estimates
Moderator
Gender

Contemplation Ladder

SOC

Boredom Reduction

RVIP

B = -62.07*

--

--

--

Anger

--

B = -.37**

B = -1.09*

B = .29*

Anxiety

--

B = -.21*

B = -.84*

B = .27*

Sadness

--

--

B = -1.09**

B = .22*

Measure

Note. * = p < .05, ** = p < .01
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Discussion
The principal aim of this study was to conduct a comprehensive, multimodal assessment
of the early time course of smoking withdrawal symptoms. Two distinct GEE models were
conducted to address this aim: main effect models and interaction models. Across assessment
periods, main effect model GEEs examined the mean difference between abstinent and smoking
participants, whereas interaction model GEEs investigated the slope (i.e., rate of change)
difference between the two groups. To determine the onset of mean difference between
participants, post hoc analyses incorporated an ANOVA at 30 minutes, followed by a progressive
series of main effect model GEEs. To determine the onset of slope difference between the two
experimental conditions, a progressive series of interaction model GEEs were conducted.
As hypothesized, we found that participants in the abstinent group exhibited greater
withdrawal, as indicated by either mean or slope difference, on all measures with the exception of
the Stroop task and the Hunger subscale of the WSWS. Impaired sustained attention and selfreported craving were the first withdrawal symptoms to emerge, reaching significance by the very
first assessment—at 30 minutes postcessation—followed by anger and decreased heart rate,
which began to appear 60 minutes after the last cigarette. The emergence of anxiety occurred at
90 minutes of abstinence, followed by perceived concentration difficulty at 150 minutes
postcessation, and finally, sadness at 180 minutes after last smoking.
To our knowledge, no previous studies had examined the early time course of smoking
withdrawal. Indeed, a unique aspect of the current investigation was its attempt to gain an
understanding of the onset of smoking-related withdrawal symptoms. The results of this study
demonstrate that symptoms are apparent as early as 30 minutes after the last cigarette.
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Contrary to expectations, we found that withdrawal measures were generally uncorrelated
with each other, with the exception of intercorrelations between the scales of the WSWS. One
interpretation of this finding is that the core indices of the tobacco withdrawal syndrome represent
distinct processes that are orthogonal in the short term. This notion is consistent with the
phenomenon of “desynchrony” found in the human fear response (Rachman & Hodgson, 1974) in
which the three indices of fear (i.e., physiological, behavioral, and affective) vary independently
of one another over time and are thought to represent three unique and independent “systems”
(see Hugdahl, 1981, and Davis & Ollendick, 2005). To be sure, each measure in the current study
was chosen for its utility in assessing a unique withdrawal-related process: physiological (heart
rate), cognitive (RVIP), attentional (Stroop), and affective (WSWS). A second and equally
plausible interpretation of this finding is that measurement variance contributed to the overall
lack of intercorrelation. Certainly, there was considerable variation in assessment method (e.g.,
physiological, computer-administrated task performance, self-report). Thus, method variance
may have overshadowed shared construct variance. This has been offered as an possible
explanation for desynchrony in the human fear response as well (e.g., Eifert & Wilson, 1991).
Finally, if we assume that heart rate deceleration is an offset effect (i.e., is not part of the
withdrawal syndrome; Shiffman et al., 2004), and consider that the Stroop task used in the current
study did not reliably distinguish between groups (i.e., was not a valid indicator of withdrawalrelated attentional bias), then it is not surprising that neither measure correlated with one another,
or with the RVIP or WSWS.
Moderation analyses were exploratory in nature and should be interpreted with caution.
The current study failed to reveal an appreciably greater number of significant moderators than
would be expected by chance alone. This is consistent with the majority of research that has
failed to find a reliable pattern of moderators of long-term withdrawal (see Hughes, 2005b).
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Limitations
There were several methodological limitations of the current investigation that should be
considered when interpreting its results. First, because the complete time course of withdrawal
was not measured (i.e., both the emergence and diminution of symptoms), it could not be
determined with certainty that the symptoms assessed in the current study were a result of
withdrawal per se. That is, they may reflect offset from the acute effects of cigarette use.
Although it is difficult to distinguish withdrawal from offset effects in all studies of abstinence,
the time-limited nature of the current study makes this distinction particularly difficult.
Therefore, it can be said only that withdrawal-related symptoms, not withdrawal itself, were
monitored. Including a nonsmoker condition might have clarified this issue in that it would have
allowed examination of whether the measured symptoms simply represented a return to
nonsmoker levels (indicating offset effects) or to levels beyond those of nonsmokers (indicating
true withdrawal symptoms.) However, this design would be confounded by possible
characterological differences between smokers and nonsmokers. The ideal design, though less
practical, would have included long-term former smokers, who are thought to most closely
resemble withdrawal-free abstinent smokers (Hughes, 2005c). This caveat regarding causality
notwithstanding, the symptoms measured in the current study should not be discounted, as
withdrawal and offset effects have the equal potential to cause distress and motivate cigarette use
(e.g., Hughes, 2005c; Hughes et al, 1990; Shiffman et al., 2004)
A second limitation of the present study is that the precise time of onset of withdrawal
symptoms could not be identified. Determining such information would have required essentially
continuous assessment of participants, which was a practical impossibility of this, and perhaps all,
conventional studies of withdrawal. The interassessment interval of 30 minutes was chosen
because it provided participants with adequate time to complete withdrawal measures, smoke (if
in the smoking condition), and rest for a period of time sufficient to reduce fatigue. Nevertheless,
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a shorter interval between assessments would have allowed for more precise measurement of
withdrawal time course.
A third limitation of the current investigation involves its ecological validity. Between
assessments, participants remained in an experimental room with magazines to read at their
leisure. Despite our attempts to create an environment with a modicum of stimulation,
participants may have found their experience to be tedious. This could have resulted in an
increase in negative affect and craving, especially among abstinent participants who were unable
to smoke as a way to alleviate boredom. Moreover, abstinent participants may have experienced
more severe symptoms of withdrawal in the laboratory than they would have in the natural
environment due to restricted access to coping mechanisms (e.g., physical activity, social
interaction). On the other hand, conditioned compensatory models of withdrawal (e.g., Siegel,
1983) would predict greater symptoms in participants’ natural smoking environments than in the
novel laboratory setting.
Although speculative, other aspects of the experimental environment may have affected
participant response. Specifically, entering through the visibly labeled doors of the Moffitt
Cancer Center’s Tobacco Research and Intervention Program may have activated a variety of
expectancies with regard to the experiment. Participants in the smoking group may have
minimized their experience of withdrawal symptoms, whereas participants in the abstinent group
may have exaggerated their symptom severity in an attempt to provide what they considered the
desired response (i.e., there may have been a demand effect). This may have been more so the
case for the WSWS, a relatively face valid measure of withdrawal, than for heart rate and the
RVIP (and, to an extent, the Stroop task), which, at face value, are not directly related to the
effects of abstinence, and are presumably under less conscious control than a self-report
questionnaire. It is also possible that the experimental setting induced a degree of self-awareness
and anxiety among smokers in both conditions, contributing to greater overall variability in the
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data (i.e., more error variance), and subsequent reduced power to detect group differences.
Nonetheless, a more neutral experimental setting may have yielded different results.
An additional limitation of the present study concerns its assessment measures. Although
we varied certain aspects of the RVIP and Stroop task with each administration to reduce practice
effects, it is possible that such effects exerted a significant influence on our results. This is
almost certainly the case with the Stroop task, which has been shown to be susceptible to a
variety of practice effects, including conscious strategies employed by participants (e.g., strategic
override), that mask attentional bias over time (see Mogg & Bradley, 1998, and Williams et al.,
1996). Indeed, research using the Stroop task with smokers has demonstrated that participants
habituate quickly to smoking-related words (cf. Waters & Feyerabend, 2000; Waters, Shiffman,
et al., 2003). It is therefore possible that the Stroop task lost its ability to measure withdrawalrelated attentional bias before such bias even existed. Of course, it is also possible that attentional
bias does not emerge during the first four hours of abstinence.
It is possible that group differences were influenced by expectancy effects. That is,
abstaining participants’ expectancies about tobacco withdrawal may have contributed to the
observed withdrawal effects (see Kirsch, 1985). This possibility could be minimized by keeping
participants blind regarding their experimental condition by, for example, administering
denicotinized cigarettes to participants in the nicotine withdrawal condition. Doing so, however,
would have attenuated the external validity of the study, in that smokers know when they are
abstaining, and expectancies may very well influence naturalistic withdrawal symptoms.
A final limitation of this study concerns its participants. Although participants were
recruited from the community and were fairly representative of the smoking population on many
characteristics (e.g., gender, smoking rate), they were required to be between 18 and 45 years old.
This restriction of age may limit the degree to which the results of this investigation can be
generalized to either adolescent or older smokers.
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Implications
Withdrawal has long been considered the dominant factor in the maintenance of and
relapse to cigarette use. Although decades of research have examined long-term withdrawal, the
present study is the first to investigate the very early time course of the tobacco withdrawal
syndrome. The current investigation has thus filled an important gap in the research literature and
has provided valuable information about a construct critical to smoking behavior.
In their natural environment, smokers have been observed to smoke approximately once
every 40 minutes (Hatsukami et al., 1988). In the present study, two withdrawal-related
symptoms (impaired sustained attention, self-reported craving) were apparent 30 minutes after
last smoking, lending support to the notion that smokers use cigarettes to alleviate withdrawal.
One interpretation of our findings is that, consistent with classic theory (e.g., Baker, Piper et al.,
2004; Benowitz, 1991; Siegel, 1983; Solomon, 1977), smokers’ moment-to-moment cigarette use
is indeed motivated by negative reinforcement. Although the affective symptoms of withdrawal
(i.e., anger, anxiety, concentration difficulty, sadness) did not emerge until 60 minutes or later,
recent theory has proposed that smoking is often motivated by preconscious levels of negative
affect (Baker, Piper, et al., 2004). Thus, negative affect may emerge earlier than the results of
this study indicate. It is possible that the majority of symptoms emerge concurrently; impaired
sustained attention and craving may represent markers of negative affect not directly detectable
by self-report. An illustrative example of this notion is that participants in the abstinent group
displayed difficulty sustaining their attention as soon as 30 minutes after their last cigarette, but
did not report having difficulty concentrating until 150 minutes postcessation.
The results of this study have important implications for the treatment of tobacco
dependence. Pharmacotherapies are considered first-line treatment for smoking cessation (Fiore
et al., 2000). Although the clinical importance of the magnitude of early-onset withdrawal
symptoms measured in this study are unknown, clinicians might consider prescribing or
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recommending the use of nicotine replacement therapies (NRTs) with relatively rapid absorption
rates (e.g., the nicotine inhaler, the nicotine nasal spray) over those that are absorbed more slowly
(e.g., the nicotine patch, the nicotine gum) for use in the very early stages of a quit attempt. Or it
may be efficacious to begin nicotine replacement prior to initiation of cessation, as is the current
recommendation regarding the non-nicotine pharmacotherapy, buproprion (Zyban). For clinicians
who provide counseling to those attempting to quit, intervention effectiveness may be enhanced
by instructing smokers to anticipate aversive withdrawal symptoms at least as early as 30 minutes
after the last cigarette, and to prepare to address these symptoms via a variety of cognitive and
behavioral coping skills.
No prior research has informed a standard method for assessing withdrawal in the short
term. Certainly, a novel aspect of the current investigation was its use of a concise (i.e.,
approximately 10 minutes), multimodal, repeated assessment of exact-moment withdrawal during
the first moments of abstinence. Given the success of this study in tracking the early time course
of withdrawal, the assessment procedure can be viewed as a framework model for measuring the
smoking withdrawal syndrome in the short term, although not without its aforementioned
constraints.
Future Research
Future studies should focus on refining the early assessment of withdrawal. There are
various ways that this could be achieved. First, the Stroop task should be excluded from the
measurement battery in favor of a more reliable measure of attentional bias that is minimally
affected by practice effects. However, given the sensitivity of heart rate, the RVIP, and the
WSWS to early withdrawal symptoms, it is unclear what advantage a measure of attentional bias
would provide. Unlike the symptoms gauged by the other three measures, attentional bias itself is
not a withdrawal symptom per se. Rather, it is considered to be an indirect measure of
withdrawal-related craving (e.g., Wertz & Sayette, 2001) that was included in this investigation
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because we anticipated that it might have revealed information that was not available to
participants’ conscious awareness. In addition, future studies could further refine the assessment
procedure by reducing test administration time. For example, researchers could develop and
implement a short form of the WSWS (or employ a briefer self-report measure), omit breath CO
assessment that was part of the current study, and perhaps employ an even briefer version of the
RVIP used in the present investigation (although abbreviating the RVIP would presumably
attenuate its reliability).
A research question posed by the results of this study involves the clinical significance of
early withdrawal symptoms. For example, how severe must symptoms be to motivate cigarette
use, and which specific symptom or symptoms seem to most powerfully motivate smoking? This
question could be answered by monitoring early withdrawal symptoms in smokers allowed to
smoke at their own pace with little or no requirements or restrictions. Researchers could then
determine the average level of withdrawal severity immediately prior to cigarette use, as well as
which symptom or symptoms are most predictive of cigarette use. A related matter of importance
is the degree to which early withdrawal symptoms cause substantial distress. This issue could be
examined by determining the degree to which: 1) others notice the withdrawal symptoms, 2)
severity of certain withdrawal symptoms compare to severity of symptoms of clinical disorders,
and 3) the withdrawal symptoms interfere with daily functioning (Hughes, 2005b). This topic
may be particularly important for acute withdrawal, given that environmental smoking
regulations (e.g., indoor bans) preclude smoking at typical intervals (i.e., smokers smoke less
frequently; see Fichtenberg & Glantz, 2002). Consequently, as these regulations become more
prevalent, smokers are likely to experience early withdrawal symptoms on an increasingly regular
basis.
Future studies should also seek to examine the early time course of withdrawal in
different populations of smokers. For example, using the present study’s assessment model, the
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short-term withdrawal syndrome can be examined in those attempting to quit, pharmacotherapy
users, smokers who have received cessation counseling, nondependent smokers (i.e., chippers),
and adolescent and older smokers. In addition, studies can incorporate cluster analyses and
hierarchical linear growth models to examine for independent groups of individuals with distinct
patterns of withdrawal symptoms (e.g., Piasecki et al., 1998, 2000, 2003a, 2003b). Future
research should also seek to investigate the early time course of withdrawal in a naturalistic (i.e.,
real-world) setting. This could be accomplished through the use of ecological momentary
assessment (EMA; Stone & Shiffman, 1994). Finally, future investigations should seek to
systematically elucidate the moderators of acute withdrawal symptoms by using carefully chosen
moderator variables and large sample sizes. Of particular interest is the effect of participants’
expectancies regarding early withdrawal. To our knowledge, no questionnaire exists that
addresses withdrawal-related expectancies. Thus, investigation of the early (and long-term) time
course of withdrawal symptoms would benefit from the development and validation of a
withdrawal expectancy questionnaire.
Given the enormous impact of cigarette use on public health, it is imperative that research
continues to examine the factors that contribute to tobacco dependence. With the continued study
of withdrawal, the field will broaden its understanding of a crucial construct related to the
problem of cigarette smoking. Ultimately, such understanding should allow for more effective
treatment of cigarette use.
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Appendix A
Demographic Questionnaire
The following questions are about you, and your life situation. They are to help us better
understand the people we serve. You are under no obligation to answer any question that you
find objectionable, however, we would appreciate your answering as many as possible. All
answers will be kept confidential.
1.

What is your age?_____________

2.

Sex: (check one)

3.

What level of education did you complete?
_____ Elementary School
_____ Business or Technical Training
_____ Junior High School
_____ Some College (no degree)
_____ Partial High School
_____ University Degree
_____ High School
_____ Post-graduate Degree

4.

What is your marital status?
_____ Single
_____ Married

□ Male

□ Female

_____ Separated
_____ Divorced

_____ Widowed

5.

With which ethnic/racial group do you most identify yourself? (please check one)
_______ Asian
_______ Native Hawaiian/Pacific Islander
_______ Black/African American
_______ American Indian/Alaska Native
_______ White/Caucasian
_______ More than one race
_______ Other
Are you Hispanic/Latino? Yes No

6.

What is your approximate personal yearly income?
______Under $10,000
______ $50,001 - $60,000
______$10,000 - $20,000
______$60,001- $70,000
______$20,001 - $30,000
______ $70,001- $80,000
______$30,001 - $40,000
______ $80,001- $90,000
______$40,001 - $50,000
______Over $90,000

7.

Total Household income?
______ Under $10,000
______ $10,000 - $20,000
______ $20,001 - $30,000
______ $30,001 - $40,000
______ $40,001 - $50,000

______$50,001 - $60,000
______$60,001- $70,000
______$70,001- $80,000
______$80,001- $90,000
______Over $90,000
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Appendix B
Drinking Information Questionnaire
About how frequently do you drink alcohol?
a)
b)
c)
d)
e)
f)
g)
h)

Never
Once a year or less
3-4 times a year
Once a month
2-3 times a month
2-3 times a week
4-5 times a week
6-7 times a week

On occasions when you drink alcohol, about how many drinks do you typically consume? Please
estimate the actual number of drinks, where:
1 drink = approximately 1 can of beer, or
= 1 glass of wine or wine cooler,
= 1 serving of liquor or a mixed drink
a)
b)
c)
d)
e)
f)
g)
h)

None
One Drink
2
3
4
5-6
7-8
9 or more
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Appendix C
Caffeine Consumption Questionnaire
On average, how many cups of caffeinated coffee do you drink per day? __________

On average, how many cups of caffeinated tea do you drink per day?

__________

On average, how many caffeinated soft drinks do you drink per day?

__________
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Appendix D
Smoking Status Questionnaire
1. Do you smoke cigarettes everyday?

□ Yes

□ No

2. How many years have you been smoking daily?_________
3. How many cigarettes do you smoke per day on average?_________
4. Do you smoke more during the first two hours of the day than during the rest of the day?
□ Yes
□ No
5. How soon after you wake up do you smoke your first cigarette?
□ Within 5 minutes
□ 6-30 minutes
□ 31-60 minutes
□ After 60 minutes
6. Which of all the cigarettes you smoke would you most hate to give up?
□ The first one in the morning
□ The one with breakfast
□ The one with lunch
□ The one with dinner
□ The last cigarette before going to bed
□ Other:_________________________
7. Do you find it difficult to refrain from smoking in places where it is forbidden (e.g., in
church, at the library)?
□ Yes
□ No
8. Do you smoke if you are so ill that you are in bed most of the day?
□ Yes
□ No
9. What brand of cigarettes do you usually smoke? ________________________________
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Appendix E
SMOKING CONSEQUENCES QUESTIONNAIRE
Instructions: This questionnaire is designed to assess beliefs people have about the consequences
of smoking a cigarette. Below is a list of statements about smoking. We would like you to rate
how LIKELY or UNLIKELY you believe each consequence is for you when you smoke. If the
consequence seems UNLIKELY to you, circle a number from 0-4. If the consequence seems
LIKELY to you, circle a number from 5-9. That is if you believe the consequence would never
happen, circle 0; if you believe a consequence would happen every time you smoke, circle 9. Use
the guide below to aid you further. For example, if a consequence seems completely likely to
you, you would circle 9. If it seems a little unlikely to you, you would circle 4.

1.
2.
3.
4.
5.

Cigarettes taste good.
Smoking controls my appetite.
Smoking reduces my anger.
Cigarettes help me concentrate
My throat burns after smoking.

0
0
0
0
0

1
1
1
1
1

2
2
2
2
2

3
3
3
3
3

4
4
4
4
4

5
5
5
5
5

6
6
6
6
6

7
7
7
7
7

8
8
8
8
8

9
9
9
9
9

6.
7.
8.
9.
10.

Cigarettes help me deal with anxiety or worry.
I enjoy the taste sensations while smoking.
Smoking helps me deal with depression.
I become more addicted the more I smoke.
If I'm tense, a cigarette helps me to relax.

0
0
0
0
0

1
1
1
1
1

2
2
2
2
2

3
3
3
3
3

4
4
4
4
4

5
5
5
5
5

6
6
6
6
6

7
7
7
7
7

8
8
8
8
8

9
9
9
9
9

11.
12.
13.
14.
15.

Cigarettes keep me from overeating.
Cigarettes help me deal with anger.
When I smoke the taste is pleasant.
Cigarettes make my lungs hurt.
If I'm dissapointed in myself, a good smoke can help.

0
0
0
0
0

1
1
1
1
1

2
2
2
2
2

3
3
3
3
3

4
4
4
4
4

5
5
5
5
5

6
6
6
6
6

7
7
7
7
7

8
8
8
8
8

9
9
9
9
9

16.
17.
18.
19.
20.

I will probably die earlier if I continue to smoke.
I will enjoy the flavor of a cigarette.
Smoking makes me seem less attractive.
I will enjoy feeling a cigarette on my tongue and lips.
Smoking will make me cough.

0
0
0
0
0

1
1
1
1
1

2
2
2
2
2

3
3
3
3
3

4
4
4
4
4

5
5
5
5
5

6
6
6
6
6

7
7
7
7
7

8
8
8
8
8

9
9
9
9
9

21.
22.
23.
24.
25.

If I have nothing to do, a smoke can help kill time.
By smoking I risk heart disease and lung cancer.
Cigarettes help me reduce or handle tension.
I enjoy parties more when I'm smoking.
People think less of me if they see me smoking.

0
0
0
0
0

1
1
1
1
1

2
2
2
2
2

3
3
3
3
3

4
4
4
4
4

5
5
5
5
5

6
6
6
6
6

7
7
7
7
7

8
8
8
8
8

9
9
9
9
9
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Appendix E (Continued)
26. When I am sad, smoking makes me feel better.
27. Cigarettes control me more and more the
longer I smoke.
28. If I'm feeling irritable, a smoke will help me relax.
29. My mouth tastes bad after smoking.
30. I like to watch the smoke from my cigarette.
31. I will become more dependent on nicotine
if I continue to smoke.
32. Smoking helps me control my weight.
33. I really enjoy a cigarette when I'm relaxed
and feeling good.
34. Cigarettes give me something to do with my hands.
35. When I’m upset with someone, a cigarette
helps me cope.
36.
37.
38.
39.
40.

The more I smoke, the more I risk my health.
Each cigarette I smoke maintains my addiction.
Cigarettes keep me from eating more than I should.
I look ridiculous while smoking.
Smoking keeps my weight down.

41. The longer I smoke, the harder it will be to quit.
42. Smoking is hazardous to my health.
43. I enjoy feeling the smoke hit my mouth
and the back of my mouth.
44. Smoking calms me down when I feel nervous.
45. Smoking irritates my mouth and throat.
46. Smoking temporarily reduces repeated
urges for cigarettes.
47. When I'm angry a cigarette can calm me down.
48. I feel more at ease with other people if I
have a cigarette.
49. Cigarettes are good for boredom.
50. Smoking is taking years off my life.
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0

1

2

3

4

5

6

7

8

9

0
0
0
0

1
1
1
1

2
2
2
2

3
3
3
3

4
4
4
4

5
5
5
5

6
6
6
6

7
7
7
7

8
8
8
8

9
9
9
9

0
0

1
1

2
2

3
3

4
4

5
5

6
6

7
7

8
8

9
9

0
0

1
1

2
2

3
3

4
4

5
5

6
6

7
7

8
8

9
9

0

1

2

3

4

5

6

7

8

9

0
0
0
0
0

1
1
1
1
1

2
2
2
2
2

3
3
3
3
3

4
4
4
4
4

5
5
5
5
5

6
6
6
6
6

7
7
7
7
7

8
8
8
8
8

9
9
9
9
9

0
0
0

1
1
1

2
2
2

3
3
3

4
4
4

5
5
5

6
6
6

7
7
7

8
8
8

9
9
9

0
0

1
1

2
2

3
3

4
4

5
5

6
6

7
7

8
8

9
9

0
0

1
1

2
2

3
3

4
4

5
5

6
6

7
7

8
8

9
9

0
0
0

1
1
1

2
2
2

3
3
3

4
4
4

5
5
5

6
6
6

7
7
7

8
8
8

9
9
9

Appendix F
Please answer the following questions if you have smoked in the past month. Each rung on this
ladder represents where various smokers are in their thinking about quitting. If you have smoked
in the last month, please circle the number that indicates where you are now.

10

Taking action to quit (e.g., cutting
down, enrolling in a program).

9
8

Starting to think about how to
change my smoking patterns.

7
6
5

Think I should quit but
not quite ready.

4
3
2

Think I need to consider
quitting someday.

1
0

No thought of quitting.
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Appendix G
SOC
If you have had a cigarette in the past 30 days, please answer the following questions.
1. Are you seriously considering quitting smoking within the next six months?
A. No
B. Yes
C. I do not smoke
2. Are you planning to quit smoking within the next 30 days?
A. No
B. Yes
C. I do not smoke
3. In the last year how many times have you quit smoking for at least 24 hours?
(If more than 9 times, put 9)
A. 0
B. 1
C. 2
D. 3
E. 4
F. 5
G. 6
H. 7
I. 8
J. 9
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Appendix H
PANAS-I
This scale consists of a number of words that describe different feelings and emotions. Read each
item and then mark the appropriate answer in the space next to that word. Indicate to what extent
you feel this way at this moment. Use the following scale to record your answers.
1
very slightly
or not at all

2
a little

3
moderately

4
quite a bit

5
extremely

______interested

______irritable

______distressed

______alert

______excited

______ashamed

______upset

______inspired

______strong

______nervous

______guilty

______determined

______scared

______attentive

______hostile

______jittery

______enthusiastic

______active

______proud

______afraid
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Appendix I
WSWS
Please answer the following questions based on how you feel or what you notice right now.
Answer based on how you feel in general at this exact moment.
0
Strongly
disagree

1

2
Disagree

3

4
Feel
neutral

5

6
Agree

7

8
Strongly
agree

1. Food is not particularly appealing to me.

0

1

2

3

4

5

6

7

8

2. I am tense or anxious.

0

1

2

3

4

5

6

7

8

3. My level of concentration is excellent.

0

1

2

3

4

5

6

7

8

4. I feel impatient.

0

1

2

3

4

5

6

7

8

5. I feel upbeat and optimistic.

0

1

2

3

4

5

6

7

8

6. I find myself worrying about my problems

0

1

2

3

4

5

6

7

8

7. I am having urges to smoke.

0

1

2

3

4

5

6

7

8

8. I feel calm.

0

1

2

3

4

5

6

7

8

9. I am bothered by the desire to smoke a cigarette.

0

1

2

3

4

5

6

7

8

10. I feel sad or depressed.

0

1

2

3

4

5

6

7

8

11. I am irritable, easily angered.

0

1

2

3

4

5

6

7

8

12. I want to nibble on snacks or sweets.

0

1

2

3

4

5

6

7

8

0

1

2

3

4

5

6

7

8

14. I feel frustrated.

0

1

2

3

4

5

6

7

8

15. I feel hopeless or discouraged.

0

1

2

3

4

5

6

7

8

16. I am thinking about smoking a lot.

0

1

2

3

4

5

6

7

8

17. I feel hungry.

0

1

2

3

4

5

6

7

8

18. It is hard to pay attention to things.

0

1

2

3

4

5

6

7

8

19. I feel happy and content.

0

1

2

3

4

5

6

7

8

0

1

2

3

4

5

6

7

8

21. It is difficult to think clearly.

0

1

2

3

4

5

6

7

8

22. I am thinking about food.

0

1

2

3

4

5

6

7

8

13. I am bothered by negative moods such as
anger, frustration, and irritability.

20. I am having trouble getting cigarettes off
my mind.
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